Correlation Between Biotechnology Ultrasector and Doubleline Global

Can any of the company-specific risk be diversified away by investing in both Biotechnology Ultrasector and Doubleline Global at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Ultrasector and Doubleline Global into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biotechnology Ultrasector Profund and Doubleline Global Bond, you can compare the effects of market volatilities on Biotechnology Ultrasector and Doubleline Global and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Ultrasector with a short position of Doubleline Global. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Ultrasector and Doubleline Global.

Diversification Opportunities for Biotechnology Ultrasector and Doubleline Global

0.35

Correlation Coefficient

Biotechnology Ultrasector  Doubleline Global

Weak diversification

The 3 months correlation between Biotechnology and Doubleline is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Ultrasector Prof and Doubleline Global Bond in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Doubleline Global Bond and Biotechnology Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Ultrasector Profund are associated (or correlated) with Doubleline Global. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Doubleline Global Bond has no effect on the direction of Biotechnology Ultrasector i.e., Biotechnology Ultrasector and Doubleline Global go up and down completely randomly.

Pair Corralation between Biotechnology Ultrasector and Doubleline Global

Assuming the 90 days horizon Biotechnology Ultrasector Profund is expected to generate 5.45 times more return on investment than Doubleline Global. However, Biotechnology Ultrasector is 5.45 times more volatile than Doubleline Global Bond. It trades about 0.02 of its potential returns per unit of risk. Doubleline Global Bond is currently generating about -0.07 per unit of risk. If you would invest  6,846  in Biotechnology Ultrasector Profund on September 2, 2024 and sell it today you would earn a total of  49.00  from holding Biotechnology Ultrasector Profund or generate 0.72% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Biotechnology Ultrasector Prof  vs.  Doubleline Global Bond

Biotechnology Ultrasector

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Biotechnology Ultrasector Profund are ranked lower than 1 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong forward indicators, Biotechnology Ultrasector is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Doubleline Global Bond

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Doubleline Global Bond has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong technical and fundamental indicators, Doubleline Global is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Biotechnology Ultrasector and Doubleline Global

The main advantage of trading using opposite Biotechnology Ultrasector and Doubleline Global positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Ultrasector position performs unexpectedly, Doubleline Global can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Doubleline Global will offset losses from the drop in Doubleline Global's long position.

The idea behind Biotechnology Ultrasector Profund and Doubleline Global Bond pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.